IOF - International Osteoporosis Foundation

Left Navigation
For Health Professionals
Top Navigation Homepage Search Sitemap Contact IOF Members Only

References for evidence-based guidelines currently available in the EU that have been appraised using the AGREE instrument

Ref. 1
Appraisal of guidelines for research and evaluation. The AGREE collaboration, September 2001.

Ref. 2
Dimai HP, Pietschmann P, Resch H, Leb G, Klaushofer K. Leitfaden zur medikamentösen Therapie der postmenopausalen Osteoporose. Wien Med Wschr 2002; 152: 596-612.

Ref. 3
Brown JP, Josse RJ and the Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Canadian Medical Association Journal 2002;167(suppl) 1-22. Website:

Ref. 4
Danish guidelines (reference to be completed)

Ref. 5
Les indications des measures quantitatives du tissu osseux: actualisation. National Agency for Accreditation & Evaluation in Health Care (ANAES), 2000

Ref. 6
Osteoporose bei Frauen nach der Menopause und im hoheren Lagensalter, Prophylaxe, Diagnose, Therapie – Emfehlungen des Dachverbandes der deutschsprachigen osteologischen Fachgesellschaften (DVO). 2003. Website:

Ref. 7
Guidelines for the Diagnosis and Management of Osteoporosis in Greece. Published in the Greek Journal of Musculoskeletal Health, vol 2, issue 4, December 2004. The improved text was also printed in a book as a HELIOS monograph pages 79, Athens 2004.
Click here to view English-language summary (PDF, 64 KB)

Ref. 8
Longoni P, Pappalepore V, Bianchi ML, Ortolani S, Sacchi G, Tempesta F. Percorsi diagnostici e terapeutici condivisi sull'osteoporosis. Editech Pharma Srl, Milan, 2001.

Ref. 9
El-Hajj Fuleihan G, Baddoura R, Awada H, Okais J, Risk P, McClung M. Lebanese guidelines on osteoporosis assessment and treatment. Journal of Clinical Densitometry (in press)
Download in PDF format (PDF, 237 KB)

Ref. 10 (Netherlands)
Osteoporose Tweede herziene richtlijn 2002.
Download in PDF format (PDF, 636 KB)
English summary published in Pols HA, Wittenberg J. CBO guideline "Osteoporosis" (second version). NTVG Ned Tijdschr Geneeskd 2002;146:1359-63.

Ref. 11 (Spain)
Guía de Práctica Clínica de la Sociedad Espanola de Investigaciones Óseas Y Metabolismo Mineral (SEIOMM). Osteoporosis Postmenopáusica 2001. Website:

Ref. 12 (UK)
Royal College of Physicians. Osteoporosis. Clinical Guidelines or prevention and treatment 1999 and Royal College of Physicians and Bone and Tooth Society of Great Britain: Update on pharmacological interventions and an algorithm for management 2000. Royal College of Physicians, London UK. Website:

Ref. 13 (UK)
Glucocorticoid-induced osteoporosis. Guidelines on prevention and treatment. Bone and Tooth Society of Great Britain, National Osteoporosis Society and Royal College of Physicians. Royal College of Physicians, London UK. Website:

Ref. 14 (Scottland)
Scottish Intercollegiate Guidelines Network (SIGN) Guidelines 56. Prevention and management of hip fracture in older people. Edinburgh, UK: SIGN, 2002 Website:

Ref. 15 (Scottland)
Scottish Intercollegiate Guidelines Network. Management of osteoporosis 2003. Website:

Ref. 16 (USA)
The National Osteoporosis Foundation (NOF) Physician's Guide to prevention and treatment of osteoporosis 2003. National Osteoporosis Foundation, Washington, DC

Ref. 17 (USA)
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis. Endocrine Practice 2003;9:545-564.

Ref. 18 (USA)
Nelson HD, Helfand M, Woolf SH, Allen JD. Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2002;137:529-541 and 526-528. Website:

Ref. 19 (USA)
North American Menopause Society (NAMS) website:

Ref. 20 (USA)
American College of Rheumatology ad hoc Committee on Glucocorticoid-induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. 2001 update. Arthritis and Rheumatism 2001;44:1496-1503.

Ref. 21 (Middle East and North Africa)
Middle East and North Africa Consensus on Osteoporosis
Ghassan MAALOUF1, Marie-Hélène GANNAGE-YARED1, Jihad EZZEDINE1, Bagher LARIJANI2 , Samir BADAWI3, Ahmad RACHED3, Leith ZAKRAOUI4, Basel MASRI5, Efteem AZAR5, Elias SABA6, Rustum NAMMARI6, Gemma ADIB7, Hikmat ABOU SAMRA7, Ziad ALRAWI8, Sami SALMAN8, Khaled EL MUNTASSER9, Rajab TARSEEN9, Wahid EL KHAROUSSI10, Mohammed AL-LAMKI10, Abdul Nasser ALOTHMAN11, Najib ALMARZOOK11, Mahmoud EL DESSOUKI12, Riad SULAIMANI12, Jamal SALEH13, Abdel Rahim SUHAILI14, Alia KHAN15, Pierre DELMAS16, Ego SEEMAN17.
1 Lebanese Osteoporosis Prevention Society;2 Endocrinology & Metabolism Center. – Shariati Hospital – Iran;3 Egyptian Osteoporosis Prevention Society;4 Tunisian Osteoporosis Prevention Society;5 Jordanian Osteoporosis Prevention Society;6 Palestinian Osteoporosis Prevention Society ;7 Syrian Council of Osteoporosis;8 Iraqi Osteoporosis Society;9 Libyan Osteoporosis Society ;10 Oman Osteoporosis Society;11 Kuwaiti Osteoporosis Society ;12 Saudi Osteoporosis Club;13 Bahrain Osteoporosis Society ;14 Gulf Osteoporosis Society ;15 Division of Endocrinology and Geriatrics – McMaster University- Canada; 16 President of IOF-Hopital Edouard Herriot-France;17 Endocrinology, Austin and Repatriation Medical Centre, University of Melbourne, Australia
Download in PDF format (PDF, 166 KB)

Back to guidelines

Page Top

Homepage | Search | Sitemap | Contact IOF | Members Only

© 2005 International Osteoporosis Foundation:
About IOF | Legal Disclaimer